Results 241 to 250 of about 547,171 (369)

Fibroblast growth factor 23 in hypophosphataemic HIV‐positive adults on tenofovir [PDF]

open access: bronze, 2012
Anneke Bech   +5 more
openalex   +1 more source

Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia. [PDF]

open access: yesInt J Oral Sci, 2023
Lira Dos Santos EJ   +9 more
europepmc   +1 more source

Engineered Chitosan‐Derived Nanocarrier for Efficient siRNA Delivery to Peripheral and Central Neurons

open access: yesAdvanced Healthcare Materials, EarlyView.
This study introduces a novel chitosan‐based nanocarrier functionalized with a neurotropic protein for efficient siRNA delivery to neurons. The polyplexes demonstrate enhanced neuronal binding, retrograde transport, and PTEN silencing, promoting axonal outgrowth.
Ana P. Spencer   +10 more
wiley   +1 more source

Association Between Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients - Comparison With B-Type Natriuretic Peptide and Cardiac Troponin T -

open access: bronze, 2010
Kazuaki Negishi   +8 more
openalex   +2 more sources

Generalizing Gelatin Methacryloyl Granular Hydrogel Fabrication Using Stable Microgels with Predictable Stiffness

open access: yesAdvanced Healthcare Materials, EarlyView.
Gelatin methacryloyl (GelMA) granular hydrogel scaffolds (GHS) are fabricated using a generalized two‐step photocrosslinking approach to yield stable (non‐dissolving) microgels suitable for in situ covalent assembly under physiological conditions. A phase diagram is developed to define the interplay between individual microgel stability and scaffold ...
Yuanhui Xiang   +4 more
wiley   +1 more source

Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects

open access: yesBasic Research in Cardiology, 2020
Marta Lindner   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy